动脉粥样硬化 SCIE

期刊简介预计审稿时间： 约3月 约7.7周

Atherosclerosis has an open access mirror journal Atherosclerosis: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.

Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The Editors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors.

《动脉粥样硬化》有一本开放获取的镜像期刊《动脉粥样硬化：X》，两者的目标和范围、编辑团队、投稿系统和严格的同行评审都相同。

《动脉粥样硬化》汇集了来自各个来源的有关研究动脉粥样硬化、其风险因素和临床表现的论文。《动脉粥样硬化》涵盖了动脉和血管生物学和疾病的基础和转化、临床和人群研究方法，以及它们的风险因素，包括：脂质和脂蛋白代谢紊乱、糖尿病和高血压、血栓形成和炎症。编辑们对涉及动脉粥样硬化和相关疾病的发病机制、环境、遗传和表观遗传基础、诊断或治疗及其风险因素的原创或评论论文感兴趣。

《Atherosclerosis》(动脉粥样硬化)编辑部通讯方式为ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。